| Citation: |
LI Zhong. Idea of Synergistic and Comprehensive Treatment of Malignant Tumors with Traditional Chinese Medicine Discussed from Theory of “Cancer State”[J]. Cancer Research on Prevention and Treatment, 2025, 52(1): 7-10. DOI: 10.3971/j.issn.1000-8578.2025.24.0771
|
Cancer is a major public health problem worldwide, and although synergistic and comprehensive treatment with traditional Chinese medicine (TCM) has made some promising achievements in recent years, the prevention and treatment situation remains considerably serious. For optimizing the role of Chinese medicine in the clinic to fight against cancer, inheriting and innovating at the same time are necessary. The author, inspired by clinical and classical theories, innovatively put forward the theory of “cancer state” and proposed that the root of cancer treatment is to change the “cancer state”. In this study, I reflect on the current situation of TCM synergistic treatment of malignant tumors and analyze “cancer state theory”, with the hope of enriching the theoretical base of TCM evidence-based treatment of malignant tumors and providing new ideas and references for the individualized use of medicines in the clinical TCM evidence-based treatment of malignant tumors.
Competing interests: The author declares that he has no competing interests.
| [1] |
The World Health Organization. Global cancer burden growing, amidst mounting need for services[J]. Saudi Med J, 2024, 45(3): 326-327.
|
| [2] |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. doi: 10.3322/caac.21834
|
| [3] |
郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2024, 46(3): 221-231. [Zheng RS, Chen R, Han BF, et al. Cancer incidence and mortality in China, 2022[J]. Zhonghua Zhong Liu Za Zhi, 2024, 46(3): 221-231.] doi: 10.3760/cma.j.cn112152-20240119-00035
Zheng RS, Chen R, Han BF, et al. Cancer incidence and mortality in China, 2022[J]. Zhonghua Zhong Liu Za Zhi, 2024, 46(3): 221-231. doi: 10.3760/cma.j.cn112152-20240119-00035
|
| [4] |
柴可群, 陈淼, 余志红, 等. 气血方、养阴方、健脾方联合化疗预防高危Ⅱ期及Ⅲ期结直肠癌术后复发转移多中心随机对照研究[J]. 中华中医药杂志, 2022, 37(2): 1158-1163. [Cai KQ, Chen M, Yu ZH, et al. Effects of Qixue Formula, Yangyin Formula and Jianpi Formula combined with chemotherapy on preventing colorectal cancer with high-risk phase Ⅱ and phase Ⅲ after operation: A multicenter randomized controlled trial[J]. Zhonghua Zhong Yi Yao Za Zhi, 2022, 37(2): 1158-1163.]
Cai KQ, Chen M, Yu ZH, et al. Effects of Qixue Formula, Yangyin Formula and Jianpi Formula combined with chemotherapy on preventing colorectal cancer with high-risk phase Ⅱ and phase Ⅲ after operation: A multicenter randomized controlled trial[J]. Zhonghua Zhong Yi Yao Za Zhi, 2022, 37(2): 1158-1163.
|
| [5] |
石建娜, 周新东, 孙科, 等. 补肾解毒方联合耳穴压豆对晚期结直肠癌患者癌性疼痛及生活质量的影响[J]. 实用临床医药杂志, 2024, 28(7): 41-44. [Shi JN, Zhou XD, Sun K, et al. Effects of Bushen Jiedu Formula combined with auricular pressure by coxherb seeds on cancer-induced pain and quality of life in patients with advanced colorectal cancer[J]. Shi Yong Lin Chuang Yi Yao Za Zhi, 2024, 28(7): 41-44.] doi: 10.7619/jcmp.20240185
Shi JN, Zhou XD, Sun K, et al. Effects of Bushen Jiedu Formula combined with auricular pressure by coxherb seeds on cancer-induced pain and quality of life in patients with advanced colorectal cancer[J]. Shi Yong Lin Chuang Yi Yao Za Zhi, 2024, 28(7): 41-44. doi: 10.7619/jcmp.20240185
|
| [6] |
刘学伟, 娄彦妮, 冯哲, 等. 从国家自然科学基金资助项目浅谈中医药在恶性肿瘤治疗中的增效减毒作用研究现状[J]. 中国中药杂志, 2022, 47(1): 253-258. [Liu XW, Lou YN, Feng Z, et al. Research status on efficacy enhancement and toxicity reduction of Chinese medicine in treatment of malignant tumors: a review of projects supported by National Natural Science Foundation of China[J]. Zhongguo Zhong Yao Za Zhi, 2022, 47(1): 253-258.]
Liu XW, Lou YN, Feng Z, et al. Research status on efficacy enhancement and toxicity reduction of Chinese medicine in treatment of malignant tumors: a review of projects supported by National Natural Science Foundation of China[J]. Zhongguo Zhong Yao Za Zhi, 2022, 47(1): 253-258.
|
| [7] |
王玉洁, 王彦晖, 奚胜艳, 等. 癌症“种子土壤说”新论[J]. 中华中医药杂志, 2018, 33(3): 975-979. [Wang YJ, Wang YH, Xi SY, et al. New discussion on ‘Seed and soil theory’ of cancer[J]. Zhonghua Zhong Yi Yao Za Zhi, 2018, 33(3): 975-979.]
Wang YJ, Wang YH, Xi SY, et al. New discussion on ‘Seed and soil theory’ of cancer[J]. Zhonghua Zhong Yi Yao Za Zhi, 2018, 33(3): 975-979.
|
| [8] |
李忠, 刘耀. 从“癌状态论”谈中医肿瘤临床思路与创新科研[J]. 中国当代医药, 2010, 17(2): 5-8. [Li Z, Liu Y. The study on clinical thinking and researching idea for the treatment of cancer from the Cancer Condition Theory[J]. Zhongguo Dang Dai Yi Yao, 2010, 17(2): 5-8.] doi: 10.3969/j.issn.1674-4721.2010.02.004
Li Z, Liu Y. The study on clinical thinking and researching idea for the treatment of cancer from the Cancer Condition Theory[J]. Zhongguo Dang Dai Yi Yao, 2010, 17(2): 5-8. doi: 10.3969/j.issn.1674-4721.2010.02.004
|
| [9] |
徐瑞华, 万德森. 临床肿瘤学[M]. 北京: 科学出版社, 2020: 2-7. [Xu RH, Wan DS. Clinical Oncology[M]. Beijing: Science Press, 2020: 2-7.]
Xu RH, Wan DS. Clinical Oncology[M]. Beijing: Science Press, 2020: 2-7.
|
| [10] |
李纪宾, 邹小农. 全球癌症流行现状及环境致癌因素解析[J]. 环境卫生学杂志, 2023, 13(11): 795-803. [Li JB, Zou XN. Global cancer epidemic status and its environmental carcinogenic factors[J]. Huan Jing Wei Sheng Xue Za Zhi, 2023, 13(11): 795-803.]
Li JB, Zou XN. Global cancer epidemic status and its environmental carcinogenic factors[J]. Huan Jing Wei Sheng Xue Za Zhi, 2023, 13(11): 795-803.
|
| [11] |
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview[J]. Int J Cancer, 2021, Online ahead of print.
|
| [12] |
de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis[J]. Lancet Glob Health, 2020, 8(2): e180-e190. doi: 10.1016/S2214-109X(19)30488-7
|
| [13] |
Chen W, Xia C, Zheng R, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment[J]. Lancet Glob Health, 2019, 7(2): e257-e269. doi: 10.1016/S2214-109X(18)30488-1
|
| [14] |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(1): 7-33. doi: 10.3322/caac.21708
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: